Factors influencing visual acuity in patients receiving anti-vascular endothelial growth factor for myopic choroidal neovascularization

Conclusion: Ranibizumab/bevacizumab therapy was effective in improving and maintaining visual acuity in myopic choroidal neovascularization. Early diagnosis, better baseline BCVA, and hyperfundus autofluorescence CNV pattern were strongly associated with better functional outcomes. Moreover, CNV distinguished by its small size and low CMT responded more favorably, achieving a better visual outcome.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research